DCF — HOLSTON VALLEY HOSP & MED CTR
Enterprise Value: $-421.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-421.4M
Enterprise Value
$-136.4M
PV of Cash Flows
$-285.0M
PV of Terminal Value
$-459.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $354.9M | $-24.6M | -7.0% | $-39.6M | $-36.0M |
| Year 2 | $365.6M | $-21.7M | -6.0% | $-37.1M | $-30.7M |
| Year 3 | $376.6M | $-18.5M | -5.0% | $-34.5M | $-25.9M |
| Year 4 | $387.9M | $-17.2M | -4.0% | $-33.6M | $-22.9M |
| Year 5 | $399.5M | $-16.7M | -4.0% | $-33.6M | $-20.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-421.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$344.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07425154936442101
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5